Third, the inclusion period of the study was long, which introduced additional heterogeneity due to the fact that several changes in the routine treatment of CRC patients occurred (e.g., RAS/BRAF/MSI is currently a routine procedure, while it was not in 2011). Here, BRAF is linked to colorectal carcinoma.